OKUR

OnKure Therapeutics
OKUR

Overview Fund Trends Analyst Outlook Journalist POV

32 hedge funds and large institutions have $38.4M invested in OnKure Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

30% less capital invested

Capital invested by funds: $55.1M → $38.4M (-$16.8M)

64% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 11

Holders
32
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$323K
2
+$117K
3
+$80.4K
4
TCM
Tang Capital Management
California
+$71.3K
5
BCM
Bridgeway Capital Management
Texas
+$58.3K

Top Sellers

1
-$490K
2
-$83.8K
3
-$49K
4
Bank of America
Bank of America
North Carolina
-$39.4K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$37K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$38.2K
27
$37.2K
28
$27.7K
29
$14K
30
$2.94K
31
$1.34K
32
$45
33
–
34
–
35
–
36
–
1
2